To The Moon

As of market close on Friday,$S&P/ASX 200(XJO.AU)$ closed at 6,791.5 point, a 2.8% increase after 5 day trading. 

Recommend to Read

Strong BUY Rated ASX Industrial Stocks, along With Their Risk Status

8 Awesome ASX Metal & Mineral Stocks with Exposure to EV Evolution

During the last 5 trading days, we can see $Brainchip Holdings(BRN.AU)$, $Liontown Resources Ltd(LTR.AU)$ ,$Magellan Financial GR(MFG.AU)$ ,$Telix Pharma(TLX.AU)$ ,$ILUKA RESOURCES LIMITED(ILU.AU)$, are the top 5 Weekly Ganers with 36.42%, 25.79%, 22.25%, 20.17%, 19.08% increases respectively.

And $Spark New Zealand(SPK.AU)$ ,$Ssr(SSR.AU)$ ,$Iamgold(IAG)$ ,$NIB Holdings(NHF.AU)$ ,$Coronado Global(CRN.AU)$ are the biggist 5 decliners of ASX stocks which market capital above AU$2 Bln.

Below are some info may related to the TOP 5 ganners'recent changes in prices:

YTDs in 2022

1. $Brainchip Holdings(BRN.AU)$ benefit from the news of 52bln Chips Act by US.

Brainchip is a global artificial intelligence (AI) chip maker with a presence in the USA, France, Australia and India. 

The US Senate passed a bill aimed at boosting computer chip manufacturing on Tuesday,The BrainChip Holdings Ltd (ASX: BRN) share price soared.

A report cited by Globe Newswire on Monday suggested the artificial intelligence (AI) market could be worth US$133.8 billion by 2030.

In early June, the company was added to the ASX 200 index. The Brainchip share price has exploded nearly 162% in the past year, while it has surged 50% YTD in 2022.

2. $Liontown Resources Ltd(LTR.AU)$ see milestone development.

According to the release, There are two good milestone recently for Liontown supported the price surge.

One is the company has appointed Lycopodium Limited (ASX: LYL) to complete the engineering, procurement, construction management (EPCM) and commissioning services for the Kathleen Valley Lithium Project in Western Australia.

Another significant milestone noted by Liontown’s managing director and CEO, Tony Ottaviano," Awarding the EPCM Contract is another significant milestone for Liontown and the development of Kathleen Valley. We are delighted to have appointed a company of Lycopodium’s stature and capability, building on their long-standing involvement with the Kathleen Valley Project in overseeing testwork, piloting and design since 2018."

$Liontown Resources Ltd(LTR.AU)$  YTD in 2022 is -31.52%.

3. $Magellan Financial GR(MFG.AU)$

The company announced the appointment of its new CEO and managing director David George to its board the past week. Magellan co-founder Hamish Douglass will transition into an advisory role, providing valuable knowledge to senior management.

By 31 May 2022, the Magellan Global Fund showed a net return of 4.9% per annum over the prior three years, underperforming the global share benchmark by an average of 6.5% per annum.

Morgans is neutral on the business with a price target of $13.43, which implies an upside of around 10%. 

Credit Suisse is neutral on the business, with a price target of $12.

$Magellan Financial GR(MFG.AU)$  YTD in 2022 is -34.02%.

4. $Telix Pharma(TLX.AU)$ see ten-fold revenue increases 

$Telix Pharma(TLX.AU)$ reports more than a ten-fold quarter-on-quarter revenue increase for the three months ending June 30. At the end of the quarter, Telix had $122.6 million in cash and an estimated 5.5 quarters left if spending levels remain the same.

Telix attributed the revenue growth to global sales of its Illuccix product which is its lead prostate cancer imaging product. The company said its Illuccix distribution network expanded from 117 to 140 radiopharmacies which aligned with its goal of expanding geographic coverage and boosting capacity in metropolitan and regional markets to offer reliable access to its product.

Cash inflows for the quarter included $5.4 million in customer receipts, up from $1.9 million in the previous quarter. Additional (non-product related) cash inflows include $17.2 million in government tax incentives for eligible R&D activities undertaken for the year ended 31 December 2021 and $1.1 million of proceeds from options exercised.

$Telix Pharma(TLX.AU)$  YTD in 2022 is -13.75%

5. $ILUKA RESOURCES LIMITED(ILU.AU)$ reported production increased much.

The company reported Zircon, rutile, and synthetic rutile production increased 5%, Total production for the quarter reached 189,000 tonnes.

Even higher fuels costs drove a $55 million increase in full-year guidance on cash costs of production,The Iluka share price also could be getting a lift after the miner revealed it had achieved a weighted average zircon price of US$1,910 per tonne, up 25% from the second half of 2021.

As at 30 June, Iluka had $600 million in net cash. The Iluka Resources Ltd (ASX: ILU) share price increased this week. YTD in 2022 is -5.86%.